Our Recommendations
- Infection prevention and control guideline for Ebola and Marburg disease, August 2023 (2023)
- Prévention et contrôle de l’infection pour les soins aux cas suspects ou confirmés de fièvre hémorragique à filovirus dans les établissements de santé, avec un accent particulier sur le virus Ebola (2014)
- Clinical care for survivors of Ebola virus disease (2016)
- Prise en charge clinique des cas de fièvre hémorragique virale (2016)
- Flambées épidémiques de maladie à virus Ebola et Marburg: préparation, alerte, lutte et évaluation (2014)
New Publications
- Infection prevention and control guideline for Ebola and Marburg disease, August 2023 (2023)
- Cocktail d’anticorps monoclonaux neutralisant REGN-EB3 contre la maladie à virus Ebola (MVE) (2022)
- Preparation and administration of REGN-EB3 for Ebola virus disease (EVD) (2022)
- Neutralizing monoclonal antibody mAb114 for Ebola virus disease (EVD) (2022)
- Neutralizing monoclonal antibody cocktail REGN-EB3 for Ebola virus disease (EVD) (2022)
Filter
37
Featured
Recommendations
17
New Publications
8
Language
Document type
No document type
26
Infographics
6
Online Courses
3
Guidelines
2
Countries / Regions
Congo, Democratic Republic of
10
Burkina Faso
8
Guinea
8
Côte d’Ivoire / Ivory Coast
7
Mali
7
Sierra Leone
6
Senegal
6
Liberia
6
Nigeria
4
Rwanda
3
Niger
3
West and Central Africa
2
Ghana
1
Togo
1
Cameroon
1
Global
1
Guinea-Bissau
1
Uganda
1
Ethiopia
1
Chad
1
Authors & Publishers
Publication Years
Category
Toolboxes
Treatment Guidelines
17
Infection Control
10
Pediatrics
6
Poster
6
Preparedness & Prevention
6
Ebola Prevention & Control
4
IPC
2
Context, Facts & Travel Advice
2
Social Mobilisation
2
Training
2
Ebola
2
Manual & Leaflet
2
Key Resources
1
WASH
1
Public Health
1
Research
1
e-Learning
1
Training Material
1
Roadmaps, Action Plans & Policies
1
Clinical Guidelines
1
Public Health
1
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
This comprehensive intermediate level course is for clinicians caring for patients with suspected or confirmed Ebola virus disease (EVD). Modules provide information on screening and triage, infection prevention and control, laboratory diagnostics, organization of the Ebola Treatment Centre (ETC), c...
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Cocktail d’anticorps monoclonaux neutralisant REGN-EB3 contre la maladie à virus Ebola (MVE)
recommended
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers.
Guidance for health care workers.
Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease
recommended
To save the lives of mothers and their babies, mitigate complications, and limit the spread of disease, it is critical that recommendations are made on the prevention, treatment, and surveillance of women who are exposed to EVD, acquire EVD during pregnancy or breastfeeding, or survive EVD with ongo...
La fièvre de Lassa est une fièvre hémorragique virale aiguë d'une durée d'une à quatre semaines qui sévit en Afrique occidentale. La fièvre de Lassa, une fièvre hémorragique virale avec des symptômes similaires à ceux de la maladie virale d'Ebola, est endémique dans une grande partie de...
Interim Guidance.
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ...
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ...
Ce document présente des recommandations sur les soins cliniques et le dépistage du virus chez les survivants de la maladie à virus Ebola. Il s'adresse principalement aux professionnels de santé qui dispensent des soins primaires aux personnes ayant survécu.
Table des matières
...
Table des matières
...
The purpose of this pocketbook is to provide clear guidance on current best management practices for VHF across health-care facilities
Guide de poche pour l’agent de santé en première ligne
Ce guide s’intéresse plus particulièrement à certaines fièvres hémorragiques virales (FHV) Ebola, Marburg, FHCC, fièvre de Lassa [et Lujo] – qui surviennent en Afrique et risquent de donner lieu à une transmission interhumaine. I...
Accessed 1 July 2014
Accessed 1 July 2014
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
